CD8A and neoplasm: Encapsulating docosahexaenoic acid (DHA) and IL-15/IL-15Rα-secreting bioengineered adipocytes reactivate NK/CD8+ T cells in ovarian and colon cancer ascites, thus enhancing NK/CD8+ T cells anti-tumor activities (58).